People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
The Alabama Poison Information Center has seen a major increase in calls relating to GLP-1 medications. Ozempic, Mounjaro, ...
19h
Medpage Today on MSNSGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney DiseaseThe dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
21h
The Brighterside of News on MSNOzempic found to reduce cravings for alcohol, heavy drinkingAlcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results